Literature DB >> 23769679

Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: severe negative syndrome may be related to a distinct lipid pathophysiology.

S-F Chen1, T-M Hu2, T-H Lan3, H-J Chiu4, L-Y Sheen5, E-W Loh6.   

Abstract

BACKGROUND: Metabolic abnormality is common among schizophrenia patients. Some metabolic traits were found associated with subgroups of schizophrenia patients.
OBJECTIVES: We examined a possible relationship between metabolic abnormality and psychosis profile in schizophrenia patients.
METHOD: Three hundred and seventy-two chronic schizophrenia patients treated with antipsychotics for more than 2 years were assessed with the Positive and Negative Syndrome Scale. A set of metabolic traits was measured at scheduled checkpoints between October 2004 and September 2006.
RESULTS: Multiple regressions adjusted for sex showed negative correlations between body mass index (BMI) and total score and all subscales; triglycerides (TG) was negatively correlated with total score and negative syndrome, while HDLC was positively correlated with negative syndrome. When sex interaction was concerned, total score was negatively correlated with BMI but not with others; negative syndrome was negatively correlated with BMI and positively with HDLC. No metabolic traits were correlated with positive syndrome or general psychopathology.
CONCLUSIONS: Loss of body weight is a serious health problem in schizophrenia patients with severe psychosis syndrome, especially the negative syndrome. Schizophrenia patients with severe negative syndrome may have a distinct lipid pathophysiology in comparison with those who were less severe in the domain.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Glucose; Lipid; Metabolism; Psychosis; Schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 23769679     DOI: 10.1016/j.eurpsy.2013.04.003

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  7 in total

1.  The prevalence and independent influencing factors of obesity and underweight in patients with schizophrenia: a multicentre cross-sectional study.

Authors:  Juan Wang; Yulong Zhang; Yating Yang; Zhiwei Liu; Lei Xia; Wenzheng Li; Zhongxiang Li; Xinhui Xie; Wenfeng Deng; Kai Zhang; Huanzhong Liu
Journal:  Eat Weight Disord       Date:  2020-06-17       Impact factor: 4.652

2.  Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia.

Authors:  Melkaye G Melka; Christina A Castellani; Richard O'Reilly; Shiva M Singh
Journal:  J Mol Psychiatry       Date:  2015-06-26

3.  Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia.

Authors:  Antoni Sicras-Mainar; Jorge Maurino; Elena Ruiz-Beato; Ruth Navarro-Artieda
Journal:  Neuropsychiatr Dis Treat       Date:  2014-12-30       Impact factor: 2.570

4.  Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms.

Authors:  Virawudh Soontornniyomkij; Ellen E Lee; Hua Jin; Averria Sirkin Martin; Rebecca E Daly; Jinyuan Liu; Xin M Tu; Lisa Todd Eyler; Dilip V Jeste
Journal:  Front Psychiatry       Date:  2019-04-23       Impact factor: 4.157

5.  Behavioral outputs of negative symptom domains of schizophrenia.

Authors:  Octavia Căpățînă; Mihaela Fadgyas Stănculete; Ioana Micluția
Journal:  Exp Ther Med       Date:  2021-05-26       Impact factor: 2.447

6.  Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals.

Authors:  Elena G Kornetova; Alexander N Kornetov; Irina A Mednova; Anastasia A Goncharova; Valeria I Gerasimova; Ivan V Pozhidaev; Anastasiia S Boiko; Arkadiy V Semke; Anton J M Loonen; Nikolay A Bokhan; Svetlana A Ivanova
Journal:  Front Psychiatry       Date:  2021-07-02       Impact factor: 4.157

7.  Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms.

Authors:  Juan Wang; Yulong Zhang; Zhiwei Liu; Yating Yang; Yi Zhong; Xiaoshuai Ning; Yelei Zhang; Tongtong Zhao; Lei Xia; Feng Geng; Rui Tao; Mei Fan; Zhenhua Ren; Huanzhong Liu
Journal:  BMC Psychiatry       Date:  2020-08-18       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.